ClinicalTrials.gg
Sign In

Corneal Diseases clinical trials

The registry lists 219 studies for Corneal Diseases across more than 10 countries. 43 are recruiting or about to start. 96 of them are mainly about Corneal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 15 narrower conditions too, such as Keratoconus: 1,045 studies, 189 open.

Get an email when these change. Save the Corneal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
113
Recruiting
33
Status unknown
29
Terminated
19
Withdrawn
9
Not yet recruiting
8

Phase

Phase 2
27
Phase 3
22
Phase 1
17
Phase 4
13
Early Phase 1
4

Where

United States
76
China
11
France
11
Egypt
10
Germany
9
Japan
8

Who runs them

National Eye Institute (NEI) (9) · Kissei Pharmaceutical Co., Ltd. (8) · National Taiwan University Hospital (4) · Tufts Medical Center (4) · Daniela Nosch (4) · Benha University (4) · Federal University of São Paulo (4) · Massachusetts General Hospital (4)

What is being tested here

Drugs under test in Corneal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexamethasone405
Daratumumab202
Lenalidomide202
Riboflavin145
Fluorometholone102
Pomalidomide101
Nirogacestat101
Ozagrel037
Moxifloxacin003
Insulin022

Drug classes tested here Corticosteroids 4 open · Angiogenesis inhibitors 3

Coming up

3phase 3 studies under way
15studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 33 Corneal Diseases studies recruiting now, 21 (64%) set no upper age limit and 5 (15%) stop at 75 or younger. 5 (15%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 8 (24%) take healthy volunteers.

Recruiting studies that take each age, of 33
AgeWomenMen
103 (9%)3 (9%)
1826 (79%)26 (79%)
3033 (100%)33 (100%)
4032 (97%)32 (97%)
5032 (97%)32 (97%)
6530 (91%)30 (91%)
7529 (88%)29 (88%)
8525 (76%)25 (76%)

Across all 219 studies, recruiting or not: 20% stop at 75 or younger and 15% at 65; 21% take children; 1% are for women only and 0% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Corneal Diseases studies take

Of 43 interventional studies with no phase under Corneal Diseases, half reached primary completion within 22 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase22 mo5–45 · 43 studies—23 mo5–54 · 37 studies
Observational16 mo12–76 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Studies

Recruiting first, then most recently updated. Showing 50 of 219. Browse all 219 → or search them.